Skin Barrier Dysfunction: Atopic Dermatitis and Beyond

Don't miss this opportunity to join us for an informative session on skin barrier dysfunction where you will learn about:

- The disorder and its role in atopic dermatitis
- The impact of immune dysregulations and microbiome abnormalities on inherent skin barrier anomalies
- Methods to study skin barrier integrity in clinical trials

Questions?

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Subscribe to our newsletter

White Paper

Centralized Monitoring: Exploring the Considerations and Challenges of Implementation

Innovaderm's Associate Director - Risk Based Quality Management, Rohit Gupta, contributed to PHUSE's white paper entitled: “Centralized Monitoring: Exploring the Considerations and Challenges of Implementation”. Innovaderm is proud to have been involved in the development of such a document addressing: 1. The key success measures & best practices to ensure a well-connected end-to-end component of […]

Blog Article

3 Tips on How to Manage Rosacea Trials

In Canada, April is dedicated to raising awareness around Rosacea. One of Innovaderm’s all-star project managers, Nalanie Johnson, shared some tips that are crucial when managing a clinical trial to the complexity of a therapeutic indication such as Rosacea: 1. In managing Rosacea studies, it is important to understand the indication and patient flow. Most […]

Case Study

Hidradenitis Suppurativa (HS) Case study

Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic - Subcutaneous Site distribution: 25 in North America and 16 in Europe […]